Which factor primarily explains the rapid onset of action for inhaled drugs?

• A. Rapid access to circulation
• B. The drug's high molecular weight
• C. Extensive first-pass metabolism
• D. Strong protein binding

Answer: (A)

Access to circulation from the lungs drives the rapid onset of inhaled drugs. When you inhale, the drug reaches the alveoli, which have a huge surface area and an extremely thin diffusion barrier. The alveolar-capillary membrane is very thin and the pulmonary blood flow is high, so the drug diffuses quickly into pulmonary veins and from there into arterial blood. That rapid entry means the drug reaches systemic tissues—and the brain—much faster than with other routes, producing effects soon after inhalation.

Other factors mentioned don’t fit as well. A high molecular weight would slow diffusion across the alveolar membrane and delay onset. Extensive first-pass metabolism would matter for oral routes; inhaled drugs largely bypass that route, contributing to quicker onset, but it’s the rapid access to circulation that primarily explains the speed. Strong protein binding affects how much free drug is available, influencing duration more than the initial speed of onset.